[go: up one dir, main page]

DE602008003816D1 - Pharmazeutische feste zubereitung mit benzazepinen und herstellungsverfahren dafür - Google Patents

Pharmazeutische feste zubereitung mit benzazepinen und herstellungsverfahren dafür

Info

Publication number
DE602008003816D1
DE602008003816D1 DE602008003816T DE602008003816T DE602008003816D1 DE 602008003816 D1 DE602008003816 D1 DE 602008003816D1 DE 602008003816 T DE602008003816 T DE 602008003816T DE 602008003816 T DE602008003816 T DE 602008003816T DE 602008003816 D1 DE602008003816 D1 DE 602008003816D1
Authority
DE
Germany
Prior art keywords
benzazepine
manufacturing
method therefor
solution preparation
pharmaceutical solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602008003816T
Other languages
English (en)
Inventor
Shinsuke Nakagawa
Kai Suzuki
Tadashi Mukai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40070798&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602008003816(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of DE602008003816D1 publication Critical patent/DE602008003816D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602008003816T 2007-06-21 2008-06-20 Pharmazeutische feste zubereitung mit benzazepinen und herstellungsverfahren dafür Active DE602008003816D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007163551 2007-06-21
PCT/JP2008/061686 WO2008156217A2 (en) 2007-06-21 2008-06-20 Pharmaceutical solid preparation comprising benzazepines and production method thereof

Publications (1)

Publication Number Publication Date
DE602008003816D1 true DE602008003816D1 (de) 2011-01-13

Family

ID=40070798

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602008003816T Active DE602008003816D1 (de) 2007-06-21 2008-06-20 Pharmazeutische feste zubereitung mit benzazepinen und herstellungsverfahren dafür

Country Status (24)

Country Link
US (4) US10905694B2 (de)
EP (1) EP2167046B1 (de)
JP (1) JP5289338B2 (de)
KR (1) KR101526625B1 (de)
CN (3) CN103463095A (de)
AR (1) AR067077A1 (de)
AT (1) ATE489944T1 (de)
AU (1) AU2008264445B2 (de)
CA (1) CA2689467A1 (de)
CY (1) CY1111939T1 (de)
DE (1) DE602008003816D1 (de)
DK (1) DK2167046T3 (de)
ES (1) ES2354030T3 (de)
HK (1) HK1201719A1 (de)
HR (1) HRP20100676T1 (de)
IL (1) IL202179A (de)
MX (1) MX2009014193A (de)
MY (1) MY147599A (de)
PL (1) PL2167046T3 (de)
PT (1) PT2167046E (de)
RU (1) RU2466717C2 (de)
SI (1) SI2167046T1 (de)
TW (1) TWI405574B (de)
WO (1) WO2008156217A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102293734A (zh) * 2010-06-25 2011-12-28 江苏恒瑞医药股份有限公司 托伐普坦固体分散体及其制备方法
CN102552278A (zh) * 2010-12-23 2012-07-11 天津泰普药品科技发展有限公司 一种提高难溶性药物托伐普坦溶出度的药物组合物
CN102228423B (zh) * 2011-06-29 2013-03-06 重庆市庆余堂制药有限公司 托伐普坦口服固体药物组合物及其制备方法
JP6057628B2 (ja) * 2012-09-06 2017-01-11 クリーンケミカル株式会社 人工透析装置のプライミング方法
TWI660748B (zh) 2013-03-01 2019-06-01 日商大塚製藥股份有限公司 用於口服投藥之包含非晶型托伐普坦（Ｔｏｌｖａｐｔａｎ）的懸浮液
TW201605488A (zh) 2013-10-15 2016-02-16 大塚製藥股份有限公司 用以預防及／或治療多囊腎病之藥物
JP6761695B2 (ja) * 2016-08-16 2020-09-30 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロース及び固形製剤
JP6838446B2 (ja) * 2017-03-22 2021-03-03 ニプロ株式会社 トルバプタン製剤およびその製造方法
JP7352175B2 (ja) * 2019-12-25 2023-09-28 ニプロ株式会社 トルバプタン製剤
CN111888335A (zh) * 2020-08-21 2020-11-06 福安药业集团重庆礼邦药物开发有限公司 一种托伐普坦的药物固体制剂及制备方法
JP2024521354A (ja) 2021-06-02 2024-05-31 エスペリオン・セラピューティクス・インコーポレイテッド ベンペド酸とトルバブタンを含む組成物及びそれらを用いた治療方法
EP4321154A1 (de) 2022-08-03 2024-02-14 Sanovel Ilac Sanayi Ve Ticaret A.S. Tablette aus tolvaptan und mindestens einem bindemittel, die mit sprühgranulation verarbeitet ist
CN120115300B (zh) * 2025-05-13 2025-08-05 洛阳栾川钼业集团股份有限公司 滑石抑制剂及其制备方法及从高滑石辉钼矿的泥精矿中回收钼的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2071511A (en) * 1934-10-01 1937-02-23 Reed & Carnrick Enteric coating
EP0450097B1 (de) 1989-10-20 1996-04-24 Otsuka Pharmaceutical Co., Ltd. Benzoheterozyklische verbindungen
TW430561B (en) * 1995-12-20 2001-04-21 Gea Farmaceutisk Fabrik As Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet
JPH09278656A (ja) 1996-02-05 1997-10-28 Sankyo Co Ltd 経口投与用５α−リダクターゼ阻害製剤及びその製造方法
DE69740161D1 (de) * 1996-11-15 2011-05-12 Ajinomoto Kk Nateglinide-Tablettenzubereitungen
JP4210355B2 (ja) * 1997-07-03 2009-01-14 大塚製薬株式会社 固形製剤組成物
JP3746167B2 (ja) * 1998-05-18 2006-02-15 武田薬品工業株式会社 医薬製剤
EP1054019A1 (de) * 1999-05-18 2000-11-22 Shin-Etsu Chemical Co., Ltd. Niedersubstituierte Hydroxypropylcellulose
JP2004530676A (ja) * 2001-04-18 2004-10-07 ノストラム・ファーマスーティカルズ・インコーポレイテッド 持続放出性薬学的組成物のための新規コーティング
JP2004026861A (ja) * 2002-06-21 2004-01-29 Shin Etsu Chem Co Ltd 濾過性に優れる水溶性セルロースエーテル及びその選定方法
JP4684545B2 (ja) 2002-09-26 2011-05-18 大日本住友製薬株式会社 溶出性の良好なイソキサゾール誘導体経口製剤
TWI322689B (en) * 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor
WO2004087109A1 (ja) * 2003-03-27 2004-10-14 Hisamitsu Pharmaceutical Co., Inc. 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
TW200507882A (en) * 2003-07-17 2005-03-01 Kyowa Hakko Kogyo Kk Solid formulations
US8158146B2 (en) * 2005-09-28 2012-04-17 Teva Pharmaceutical Industries Ltd. Stable combinations of amlodipine besylate and benazepril hydrochloride

Also Published As

Publication number Publication date
US10905694B2 (en) 2021-02-02
MX2009014193A (es) 2010-01-28
US20100323006A1 (en) 2010-12-23
RU2010101797A (ru) 2011-07-27
HK1201719A1 (en) 2015-09-11
RU2466717C2 (ru) 2012-11-20
CN103989644A (zh) 2014-08-20
BRPI0813100A2 (pt) 2014-12-23
HRP20100676T1 (hr) 2011-01-31
EP2167046A2 (de) 2010-03-31
KR101526625B1 (ko) 2015-06-05
TW200911270A (en) 2009-03-16
CA2689467A1 (en) 2008-12-24
CN103463095A (zh) 2013-12-25
IL202179A (en) 2012-10-31
SI2167046T1 (sl) 2011-03-31
PL2167046T3 (pl) 2011-05-31
WO2008156217A2 (en) 2008-12-24
MY147599A (en) 2012-12-31
IL202179A0 (en) 2010-06-16
AU2008264445A1 (en) 2008-12-24
AU2008264445B2 (en) 2013-06-27
US20230321113A1 (en) 2023-10-12
PT2167046E (pt) 2011-02-10
US20210069207A1 (en) 2021-03-11
AR067077A1 (es) 2009-09-30
JP5289338B2 (ja) 2013-09-11
ES2354030T3 (es) 2011-03-09
ATE489944T1 (de) 2010-12-15
WO2008156217A3 (en) 2009-02-26
KR20100038386A (ko) 2010-04-14
TWI405574B (zh) 2013-08-21
EP2167046B1 (de) 2010-12-01
JP2010530355A (ja) 2010-09-09
CY1111939T1 (el) 2015-11-04
DK2167046T3 (da) 2011-01-31
US20210113582A1 (en) 2021-04-22
CN101686941A (zh) 2010-03-31

Similar Documents

Publication Publication Date Title
DE602008003816D1 (de) Pharmazeutische feste zubereitung mit benzazepinen und herstellungsverfahren dafür
EP1992348A4 (de) Pharmazeutische kombination
ATE488227T1 (de) Feste zubereitung mit alogliptin und pioglitazon
EP2037917A4 (de) Pharmazeutische zusammensetzung mit amlodipin und losartan
EP2211885A4 (de) Kombinationstherapie mit antikörper-arzneimittel-konjugaten
HUE053357T2 (hu) Gyógyszerészeti készítmény és annak beadásai
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
ATE501064T1 (de) Kapsel mit reduziertem nachtropfen
EP2170222A4 (de) Medizinisches implantat mit keramikschicht
EP2085078A4 (de) Osmotische osmosepumpe mit hochpermeablen arzneimitteln in tablettenform mit kontrollierter porosität und ihr herstellungsverfahren
ZA200706495B (en) Tablets with improved drug substance dispersibility
ATE493119T1 (de) Pharmazeutische zusammensetzung
SI2230932T1 (sl) Oplaščeni farmacevtski ali nutracevtski pripravek s povečanim sproščanjem aktivne učinkovine v črevesu
PL1957073T3 (pl) Substancja lecznicza
EP2341047A4 (de) Cyclohexanderivat und pharmazeutische anwendung davon
DK2182988T3 (da) Radiofarmaceutisk præparat
EP2193795A4 (de) Latanoprosthaltige wässrige pharmazeutische zusammensetzung
DE602008005137D1 (de) Chinolonverbindung und pharmazeutische zusammensetzung
EP2098513A4 (de) Tricyclische verbindung und ihre pharmazeutische verwendung
BRPI0922888A2 (pt) administração combinada de fármaco
EP2156832A4 (de) Pharmazeutische zusammensetzung
EP2123376A4 (de) Stopfenstruktur und herstellungsverfahren dafür
ATE530164T1 (de) Wässrige pharmazeutische zubereitung
IL195618A0 (en) Drug administration methods
EP1889613A4 (de) Pharmazeutische zusammensetzung mit vitamin k